BSX · Earnings call · 2026Q3T · Full report

China Pricing Pressure

BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 15 · Surprise 24

Management said pricing dynamics in China have become more challenging, with VBP and other pricing effects affecting a number of businesses. It expects growth in the market to moderate to single digits and anticipates additional price headwinds in 2027. Management also identified China pricing as a drag on 2027 growth and gross margin.

Key facts

• Boston Scientific expects additional price headwinds in China in 2027, likely insufficiently offset by growth in the rest of the business to offset EP and WATCHMAN pressure.
• Boston Scientific expects growth in China to moderate to single digits as VBP and other pricing impacts evolve.